Lonza: Strong H1 Execution, Higher Guidance Means Higher Upside (OTCMKTS:LZAGY)
· seekingalpha.com
Lonza's Integrated Biologics, Advanced Synthesis, and Specialized Modalities each delivered double-digit growth. Read why LZAGY stock is a Buy.
Here at the Lab, we are back to comment on Lonza Group AG ( LZAGY ) ( LZAGF ), following the company's H1 release. In our last update, we continued to buy-rate ...